Given that some sex-dependent differences have been observed in 3xTg-AD mice (Barber et al., 2024; Dennison et al., 2021), future studies will test the therapeutic efficacy of SNAP-AD5 vaccine in male 3xTg-AD mice. This evidence concerns the gene PSEN2 and Alzheimer disease.